Biotechnology
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic
SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130), a biotechnology company developing innovative therapeutics in immune-oncology, announced today thatthe United States (US) Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) applic...
2020-04-20 14:41
3311
Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
SUZHOU, China, April 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 1801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major dis...
2020-04-20 08:00
8623
Fondazione Internazionale Menarini Creates a New Covid-19 "Virtual" Library for Doctors and Nurses: It Takes Only a Click to get the Studies Chosen by Nobel Ignarro
FLORENCE, Italy, April 17, 2020 /PRNewswire/ -- Created by the Menarini International Foundation, the collection of the most distinguished and influential scientific publications on Covid-19, selected and constantly updated under the guidance of the Nobel Prize for Medicine Louis J. Ignarro, mem...
2020-04-17 03:32
3471
Kaneka Agrees to Supply Active Pharmaceutical Ingredients for Avigan® Tablet
TOKYO, April 16, 2020 /PRNewswire/ -- Kaneka Corporation (President: Minoru Tanaka) has reached an agreement with FUJIFILM Corporation (President: Kenji Sukeno) to supply drug substances for anti-influenza drug, Avigan® Tablet (generic name: favipiravir), for the novel coronavirus disease (referr...
2020-04-16 23:33
3355
Atomo Diagnostics to list on ASX after successful IPO and virtual bell ringing ceremony
SYDNEY, April 16, 2020 /PRNewswire/ -- Following an oversubscribed initial public offering and the first ASX virtual bell ringing listing, trading of shares in Australian rapid blood test company Atomo Diagnostics Limited (Atomo) commenced on the Australian Securities Exchange (ASX) today under t...
2020-04-16 11:15
8812
ACRO Biomedical's Proprietary Technology Leads the World with Patents from Taiwan, Japan, USA, and Korea
TAIPEI, April 16, 2020 /PRNewswire/ -- ACRO Biomedical Co., Ltd., the first company in the world to utilize "supercritical CO2 extraction technology" on cleansing animal tissues and organs, is gradually showing impressive results on the global patent map. In 2019, ACRO acquired two patents fromJa...
2020-04-16 09:20
2759
Prenetics, Prudential, and others launch Project Screen - a non-profit initiative providing a WHO-approved solution to get tested and diagnosed for COVID-19 from home in Hong Kong
HONG KONG, April 15, 2020 /PRNewswire/ -- Leading genetic testing and digital health company Prenetics (also known as CircleDNA) today announces the launch of Project Screen by Circle – the initiative is backed by philanthropic and operational support from a consortium of industry leaders, incl...
2020-04-15 23:59
2656
Ansun Biopharma Enrolls First Patient in Proof of Concept Trial of DAS181 for the Treatment of COVID-19
New study will build on recent clinical evidence showing efficacy of DAS181 in improving symptoms of patients with severe COVID-19 Clinical study initiated at 12 US sites, including leading academic medical centers SAN DIEGO, April 15, 2020 /PRNewswire/ -- Ansun Biopharma, Inc., a clinical sta...
2020-04-15 19:00
1870
Revolutionary Machine Learning Company Identifies Two Possible Treatments for Intractable Breast Cancer Type
Pattern Computer has received positive national lab results for combination therapy drug candidates targeting basal-like breast cancer REDMOND, Washington, April 14, 2020 /PRNewswire/ -- Pattern Computer®, Inc. has received confirmation from Lawrence Berkeley National Laboratory that drug therap...
2020-04-14 20:27
2310
Seegene Receives Health Canada Approval for its COVID-19 Assay
SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale inCanada of Seegene's Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVI...
2020-04-13 21:00
2337
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
SHANGHAI and MELBOURNE, Australia, April 13, 2020 /PRNewswire/ -- Antengene Corporation today announced the appointment of Mr. Thomas Karalis as Head of Asia Pacific Regions. In this position, Tom will be responsible for the commercialization of Antengene products inAustralia, New Zealand, S. Kor...
2020-04-13 20:00
3377
Ascletis Receives IND Approval for its HIV Drug ASC09F
HANGZHOU and SHAOXING, China, April 13, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F (ASC09/Ritonavir Fixed-Dose C...
2020-04-13 20:00
3588
EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries
PROVIDENCE, Rhode Island, April 8, 2020 /PRNewswire/ -- EpiVax, Inc., is using advanced computational tools to accelerate a COVID-19 vaccine candidate (EPV-CoV19) for healthcare workers (HCW) into clinical trials in 6 months. Today, EpiVax announces its partnership with GAIA Vaccine Foundation ("...
2020-04-08 03:57
2582
Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
- CRISPR-chrom technology improves access to genome for more efficient editing - Only U.S. patent holder in the CRISPR chromatin space - Company driving innovation in CRISPR gene-editing technologies DARMSTADT, Germany, April 7, 2020 /PRNewswire/ -- Merck, a leading science and technology compan...
2020-04-07 20:00
3025
CROMSOURCE Announces Launch of COVID-19 Clinical Trial
VERONA, Italy, 7 April, 2020 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) with its global headquarters inVerona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial is expected to be pe...
2020-04-07 19:01
2682
CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality
SUZHOU, China, April 3, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Mr. Ye Shi as the Head of Quality. He will be responsible for the overall management of the qual...
2020-04-03 09:12
4921
Atomo secures significant European sales agreement for rapid COVID-19 tests as $30m Initial Public Offer closes oversubscribed
SYDNEY, April 3, 2020 /PRNewswire/ -- Australian rapid blood test company Atomo Diagnostics Limited today said it had entered into a binding supply agreement with French diagnostics company, NG Biotech, SAS (NG Biotech), for the supply of Atomo's integrated blood test devices to NG Biotech to use...
2020-04-02 21:01
2112
Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment
Treatment with DAS181, a clinical-stage recombinant biologic, reduced or eliminated the need for supplemental oxygen, and improved key patient vital signs SAN DIEGO, April 2, 2020 /PRNewswire/ -- Ansun Biopharma, Inc., a clinical stage biopharmaceutical company, today announced preliminary data ...
2020-04-02 19:00
2245
Neteera, the Global Leader in Contact-free Vital Signs Monitoring, Launches Contactless Vital Signs Sensing System for COVID-19 Early Screening and Home Care
JERUSALEM, March 31, 2020 /PRNewswire/ -- As the world grapples with the current COVID-19 (Coronavirus) pandemic, the spotlight has been thrown on the interface between those afflicted by the virus, and the infrastructure delivering essential treatment to those in urgent need. It is precisely at...
2020-04-01 13:37
2624
GenScript Biotech Reports 2019 Financial Results and Provides Business Update
NANJING, China, April 1, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, yesterday reported full year 2019 financial results and provided a corporate update. In 2019, overall revenue of the Group was approximatelyUS$273.4 million, repres...
2020-04-01 08:36
12913
Week's Top Stories
Most Reposted
PARKROYAL COLLECTION MARINA BAY IS THE FIRST HOTEL IN SINGAPORE TO ATTAIN THREE PRESTIGIOUS SUSTAINABILITY CERTIFICATIONS
[Picked up by 323 media titles]
2024-12-19 13:41
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 309 media titles]
2024-12-20 16:25
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
[Picked up by 308 media titles]
2024-12-19 17:56
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 306 media titles]
2024-12-20 18:11
XTransfer and OCBC Jointly Announce Comprehensive Partnership
[Picked up by 263 media titles]
2024-12-23 17:36
Most Read
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
2024-12-20 18:11
9425
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
2024-12-19 17:56
9076
